Skip to main content

Disruptive Behavior clinical trials at UCSD
1 in progress, 0 open to new patients

  • Prazosin for Agitation in Alzheimer's Disease

    Sorry, not yet accepting patients

    The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease. Two thirds of the participants will participate in the medication portion, while one third will participate in the placebo portion

    San Diego, California and other locations

Last updated: